Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ERIS | NSE
-56.40
-3.94%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
21/04/2026
1,376.00
1,445.00
1,450.40
1,339.10
Eris Lifesciences Limited manufactures markets and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas such as cardiovascular anti"diabetes anti-infective antipyretics vitamins/nutrients gastroenterology respiratory gynecology pediatrics neurology psychiatry and pain/analgesics as well as in-vitro fertilization cosmetology and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad India."
View LessLow Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High Current Volume and Negative 1-Day Return
Midcap (2B - 10B USD)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
36.8%1 month
34.8%3 months
33.7%6 months
32.7%48.08
24.04
7.08
1.08
0.39
30.01
10.53
-
7.40B
187.55B
2.01B
-
24.32
-12.50
55.60
14.59
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
181.20
Range1M
242.00
Range3M
293.00
Rel. volume
5.00
Price X volume
806.38M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Limited | DRREDDY | Drug Manufacturers-Specialty & Generic | 1220.6 | 203.34B | -0.97% | 20.23 | 10.41% |
| Piramal Pharma Limited | PPLPHARMA | Biotechnology | 150.81 | 199.37B | 1.36% | 805.68 | 59.54% |
| NATCO Pharma Limited | NATCOPHARM | Drug Manufacturers-Specialty & Generic | 1055.65 | 189.08B | -4.04% | 15.31 | 6.34% |
| Syngene International Limited | SYNGENE | Biotechnology | 444.65 | 178.39B | 1.88% | 71.45 | 13.66% |
| Granules India Limited | GRANULES | Drug Manufacturers-Specialty & Generic | 667.75 | 161.84B | 0.50% | 29.41 | 40.77% |
| Alembic Pharmaceuticals Limited | APLLTD | Drug Manufacturers-Specialty & Generic | 764.3 | 153.15B | 0.90% | 36.23 | 10.65% |
| Jubilant Pharmova Limited | JUBLPHARMA | Drug Manufacturers-Specialty & Generic | 906.95 | 141.58B | 0.16% | 33.46 | 67.43% |
| Caplin Point Laboratories | CAPLIPOINT | Drug Manufacturers-Specialty & Generic | 1748.8 | 132.93B | -0.31% | 30.77 | 0.09% |
| Concord Biotech Limited | CONCORDBIO | Biotechnology | 1043.7 | 110.21B | -2.13% | 67.34 | 0.64% |
| JUBILANT INGREVIA LTD | JUBLINGREA | Biotechnology | 658.75 | 102.81B | -1.29% | 67.54 | 27.04% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| AFFLE | AFFLE | Advertising Agencies | 1462.9 | 204.59B | 1.25% | 67.64 | 7.31% |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 450.85 | 110.28B | 0.48% | 84.26 | 27.74% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 50.53 | 44.32B | -5.04% | 48.67 | 10.74% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 271.87 | 15.94B | 0.54% | 30.54 | 80.30% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 100.64 | 14.83B | -0.92% | 28.83 | 43.67% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 197.59 | 7.05B | 3.12% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 214.72 | 6.94B | -0.03% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 61 | 1.68B | -1.98% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 93.13 | 1.35B | 1.38% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 74.4 | 829.47M | -0.24% | 50.06 | 4.88% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 30.01 | 24.85 | Expensive |
| Ent. to Revenue | 10.53 | 11.40 | Par |
| PE Ratio | 48.08 | 51.36 | Par |
| Price to Book | 7.08 | 6.83 | Par |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 33.69 | 42.17 | Lower Risk |
| Debt to Equity | 1.08 | 0.35 | Expensive |
| Debt to Assets | 0.39 | 0.17 | Expensive |
| Market Cap | 187.55B | 290.82B | Emerging |